SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-09
👔
Retension Pharmaceuticals, Inc.
@RTSN_InsiderForm 4 Filing: BERENDT MICHAEL J Acquires (Grant) shares of $RTSN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Retension Pharmaceuticals, Inc.
Ticker: $RTSN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-10-08
Shares: 5,636
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BERENDT MICHAEL J, holds the title of Director at Retension Pharmaceuticals, Inc..
On 2026-10-08, the insider transacted 5,636 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
BERENDT MICHAEL J (Director) was granted $0 of $RTSN
Post-Transaction Position: 5,636 shares
SEC Accession No: 0001213900-26-108190 (CIK: 1186877)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.